Winclas Cream

Introduction

Winclas Cream 1% w/w is a topical anti-androgen medication used primarily in the treatment of acne. It is designed to inhibit the effects of androgens on the skin, which can contribute to acne development.

Uses

Winclas Cream 1% w/w is used for the topical treatment of acne vulgaris in individuals aged 12 years and older. It targets androgen receptors in the skin to help reduce the production of sebum, a contributing factor to acne.

Brand Name	Winclas
Type	Cream
Weight	1% w/w
Generic	Clascoterone
Manufacturer	Incepta Pharmaceuticals Ltd.
Available in	English বাংলা

Mechanism of Action

Winclas Cream 1% w/w acts as a topical anti-androgen by selectively binding to androgen receptors in the skin. This binding inhibits the action of androgens, which are hormones that can stimulate sebaceous gland activity and lead to acne. By reducing androgen activity locally, Winclas Cream 1% w/w decreases sebum production and helps prevent acne formation.

How Long Does It Take to Work?

Initial improvements in acne symptoms may be observed within 4-8 weeks of starting Winclas Cream 1% w/w treatment. However, optimal results typically take several months to achieve, as with most acne treatments. Continued use is often necessary to maintain benefits and prevent recurrence of acne.

Absorption

Winclas Cream 1% w/w is applied topically and is minimally absorbed into systemic circulation. Its primary action is localized to the skin where it exerts its effects on androgen receptors.

Route of Elimination

Since Winclas Cream 1% w/w is used topically, it has minimal systemic absorption. Its elimination primarily occurs through metabolic processes in the skin and subsequent excretion via the body’s natural elimination pathways.

Dosage

Clean the affected area gently then apply a thin uniform layer (approximately 1 gm) of Clascoterone
cream twice per day in the morning and evening to the affected area. Avoid accidental transfer of Clascoterone cream into eyes, mouth, or other mucous membranes. If contact with mucous membranes occurs, this should be rinsed thoroughly with water or as directed by physician.

Use in Children and Adolescents: Safety and effectiveness of Clascoterone cream for the topical treatment of acne vulgaris have not been established in pediatric patients under 12 years of age

The typical dosage for Winclas Cream 1% w/w is to apply a thin layer of the topical solution to the affected areas of the skin twice daily. The specific dosage and frequency should be determined based on the severity of the acne and the patient's response to treatment.

Administration

Winclas Cream 1% w/w should be applied to clean, dry skin. It is important to follow the prescribed application guidelines, using a small amount to cover the affected areas. Avoid applying the medication to broken or irritated skin.

Side Effects

Common side effects of Winclas Cream 1% w/w may include:

Skin irritation
Redness or dryness at the application site
Itching

Serious side effects are rare but may include:

Severe allergic reactions
Severe skin irritation

Toxicity

Due to its topical application and minimal systemic absorption, Winclas Cream 1% w/w has a low risk of systemic toxicity. Overuse or accidental ingestion of the product can cause localized skin irritation or other symptoms, and medical attention should be sought if significant adverse effects occur.

Precautions

Precautions include:

Avoid contact with eyes, lips, and mucous membranes.
Do not use on open wounds or severely irritated skin.
Monitor for signs of severe irritation or allergic reaction.

Interaction

Interactions with other topical products are possible. It is advisable to avoid using other topical acne treatments or products that may cause skin irritation unless directed by a healthcare provider.

Disease Interaction

Use Winclas Cream 1% w/w with caution in individuals with skin conditions such as eczema or psoriasis, as these conditions may be exacerbated by topical treatments.

Drug Interaction

Since Winclas Cream 1% w/w is applied topically, systemic drug interactions are unlikely. However, combining it with other topical medications should be done with caution and under medical advice to avoid potential additive effects or irritation.

Food Interactions

There are no known food interactions with Winclas Cream 1% w/w. It is applied topically, so it does not interact with food when used as directed.

Pregnancy Use

The safety of Winclas Cream 1% w/w during pregnancy has not been fully established. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Consult a healthcare provider before use if pregnant or planning to become pregnant.

Lactation Use

It is not known whether Winclas Cream 1% w/w is excreted in breast milk. Caution should be exercised when using Winclas Cream 1% w/w while breastfeeding, and a healthcare provider should be consulted to assess potential risks and benefits.

Acute Overdose

In the event of an acute overdose, symptoms may include severe skin irritation. If excessive amounts of Winclas Cream 1% w/w are applied or ingested, remove the product from the skin and seek medical attention if necessary.

Contraindication

Winclas Cream 1% w/w is contraindicated in individuals with known hypersensitivity to the drug or its components. It should not be used on broken or severely irritated skin.

Use Direction

Apply Winclas Cream 1% w/w as directed by a healthcare provider, typically to clean, dry skin. Avoid using more than the recommended amount, and follow all application instructions carefully.

Storage Conditions

Store Winclas Cream 1% w/w at room temperature, away from direct sunlight and moisture. Keep the container tightly closed and out of reach of children.

Volume of Distribution

As a topical medication, Winclas Cream 1% w/w has minimal systemic distribution. Its primary action is localized to the skin where it is applied.

Half Life

The half-life of Winclas Cream 1% w/w in the skin is not well-defined due to its topical application and minimal systemic absorption. Its effects are primarily related to its local action rather than systemic pharmacokinetics.

Clearance

Winclas Cream 1% w/w is primarily cleared from the body through metabolic processes in the skin and is minimally absorbed into systemic circulation. Therefore, systemic clearance data is not typically applicable.

See in details version Winclas Cream 1% w/w also Winclas Cream 1% w/w in bangla